Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.73 |
| ▸ | ALPI | P09923 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | XIAP | P98170 | 1/20 | 0.60 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.60 |
| ▸ | LTA4H | P09960 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | NOS1 | P29475 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2130589 | 1.00 | GRIK1 (0.73) | GRIK1ALPIPKMPTGS1XIAP | |
| SCHEMBL5082998 | 1.00 | GRIK1 (0.73) | GRIK1ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL7359673 | 0.98 | GRIK1 (0.71) | GRIK1ALPIPKMPTGS1XIAP | |
| Hydrochloric Acid SCHEMBL27975738 | 0.98 | GRIK1 (0.71) | GRIK1ALPIPKMPTGS1XIAP | |
| SCHEMBL372365 | 0.94 | GRIK1 (0.66) | GRIK1ALPIPKMPTGS1XIAP | |
| SCHEMBL3390123 | 0.94 | GRIK1 (0.66) | GRIK1ALPIPKMPTGS1XIAP | |
| SCHEMBL28465699 | 0.94 | GRIK1 (0.66) | GRIK1ALPIPKMPTGS1XIAP | |
| SCHEMBL23176817 | 0.93 | GRIK1 (0.64) | GRIK1ALPIPKMPTGS1XIAP | |
| SCHEMBL3664379 | 0.93 | GRIK1 (0.64) | GRIK1ALPIPKMPTGS1XIAP | |
| SCHEMBL17686506 | 0.93 | GRIK1 (0.64) | GRIK1ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 484 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099897-A1 | NOVEL LINKERS AND ITS PREPARATION METHODS THEREOF | ZYDUS LIFESCIENCES LIMITED (IN) | 2026-05-15 | — | — | WO | claimed |
| US-20220135622-A1 | ANTIBACTERIAL PEPTIDES AND METHODS OF USE | GENENTECH, INC. (US) | 2022-05-05 | — | — | US | claimed |
| CN-107592865-B | Peptidomimetic compounds for neutralizing influenza viruses | 扬森疫苗与预防公司 | 2022-01-25 | — | — | CN | claimed |
| EP-3931205-A1 | ANTIBACTERIAL PEPTIDES AND METHODS OF USE | Genentech, Inc. (US) | 2022-01-05 | — | — | EP | claimed |
| CN-113788877-A | Novel insect kinin analogs and application thereof in aphid control | 中国农业大学 | 2021-12-14 | — | — | CN | claimed |
| CN-113490682-A | Antimicrobial peptides and methods of use thereof | 豪夫迈·罗氏有限公司 | 2021-10-08 | — | — | CN | claimed |
| US-20200399311-A1 | NOVEL PEPTIDE BASED PCSK9 VACCINE | ZYDUS LIFESCIENCES LIMITED (IN) | 2020-12-24 | — | — | US | claimed |
| US-10738083-B2 | Influenza virus neutralizing peptidomimetic compounds | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2020-08-11 | — | — | US | claimed |
| EP-3609532-A1 | NOVEL PEPTIDE BASED PCSK9 VACCINE | Cadila Healthcare Limited (IN) | 2020-02-19 | — | — | EP | claimed |
| CN-110536696-A | PCSK9 vaccine based on new peptide | CADILA HEALTHCARE LTD | 2019-12-03 | — | — | CN | claimed |
| CN-102405229-A | Short-chain peptides as parathyroid hormone (PTH) receptor agonists | CADILA HEALTHCARE LTD | 2012-04-04 | — | — | CN | claimed |
| WO-2010128521-A2 | SHORT-CHAIN PEPTIDES AS PARATHYROID HORMONE (PTH) RECEPTOR AGONIST | CADILA HEALTHCARE LIMITED (IN) | 2010-11-11 | — | — | WO | claimed |
| CN-101400699-A | Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions | BRISTOL MYERS SQUIBB CO (US) | 2009-04-01 | — | — | CN | claimed |
| EP-1976873-A2 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS | Brystol-Myers Squibb Company (US) | 2008-10-08 | — | — | EP | claimed |
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY | 2007-10-11 | — | — | US | claimed |
| WO-2007082264-A2 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-07-19 | — | — | WO | claimed |
| WO-2003087036-A1 | STEREOSELECTIVE PROCESS FOR THE SYNTHESIS OF (D)-2-AMINO-5-PHENYLPENTANOIC OR ALKYL ESTER THEREOF | ELI LILLY AND COMPANY (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030032774-A1 | Novel opioid peptides for the treatment of pain | ASTRAZENECA AB | 2003-02-13 | — | — | US | claimed |
| EP-1164141-A2 | Opioid peptides and their use for treatment of pain | AstraZeneca AB (SE) | 2001-12-19 | — | — | EP | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238669-A1 | HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS | GLP1R, GIPR, IAPP | GRIK1 1402/4885ALPI 301/4885PKM 2260/4885 |
| US-10738083-B2 | Influenza virus neutralizing peptidomimetic compounds | ANPEP, NEU1, NGLY1 | GRIK1 3250/4885ALPI 2864/4885PKM 3875/4885 |
| US-20030032774-A1 | Novel opioid peptides for the treatment of pain | OPRL1, OPRK1, OPRM1 | GRIK1 291/4885ALPI 4275/4885PKM 2837/4885 |
| US-20200399311-A1 | NOVEL PEPTIDE BASED PCSK9 VACCINE | PCSK9, PCSK7, PCSK6 | GRIK1 3666/4885ALPI 509/4885PKM 1974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.